Indications and uses
Helps prevent sunburn Higher SPF gives more sunburn protection
Helps prevent sunburn Higher SPF gives more sunburn protection
Apply generously 30 minutes before sun exposure and as needed. Do not spray on face. Spray on hands and rub well into face and scalp. Reapply every 2 hours, or after swimming, excessive perspiration, towel drying or extended sun exposure. Children under 6 months of age: ask a doctor. Effective sun protection for children under 2 years of age is strongly recommended.
Avobenzone 3.00% .............Sunscreen
Octisalate 5.00% ...................Sunscreen
Octocrylene 2.75%
............... Sunscreen
Helps prevent sunburn
Higher SPF gives more
sunburn protection
For external uses only.
When using this
product keep out of eyes.
Rinse with water to
remove.
Stop use and ask a doctor if rash or irritation
develops and lasts.
use in well ventilated areas.
Do not
puncture or incinerate.
Contents under pressure.
Do not
store above 1200F/480C.
Avoid long term storage above
1040F/400C.
FLAMMABLE.
Do not use near heat, flame or
while smoking.
Apply generously 30 minutes before sun exposure and
as needed.
Do not spray on face.
Spray on hands and rub
well into face and scalp.
Reapply every 2 hours, or after
swimming, excessive perspiration, towel drying or extended sun
exposure.
Children under 6 months of age: ask a
doctor.
Effective sun protection for children under 2 years of
age is strongly recommended.
Sun alert: Limiting sun exposure, wearing
protective clothing, and using sunscreen may reduce the risk of skin
aging, skin cancer, and other harmful effects of the sun.
May
stain clothing.
You may report serious adverse reactions to
Report Reactions, LLC, PO Box 22, Plainsboro, NJ
08536-0222
SD Alcohol 40, Butyloctyl Salicylate, Polyester-8,
Cyclopentasiloxane, Diethylhexyl Syringylidene Malonate, Diisopropyl
Adipate, Acrylates/Octylacrylamides Copolymer, Caprylic/Capric
Triglyceride, Tetrahexyldecyl Ascorbate
NO TOUCH BODY SPRAY
Easy Application, Non-Greasy and Quick Drying
Sunscreen For Active Lifestyles
Quick drying non-propellant spray
Non-oily spray
Broad Spectrum Protection
UVB ("Buring" rays" SPF 40
UVA ("Aging" rays) Formulated to meet European standards
Also available from MDSolarSciences:
Ultra Mineral Screeen Gel SPF 50+
Ultra-Sport Stick SPF 40
Mineral Screen Lotion SPF 40
Mineral Screen Gel SPF 30+
SDS-CT-229
MDSolarSciences Corp
www.mdsolarsciences.com
40 Richards Avenue, 3rd Floor, Norwalk, CT 06854
Patent Pending
UPC 8 55488 00200 4
A complete sun protection routine
can help to reduce photo-aging and
the incidence of skin cancer.
The use of broad spectrum (UVA
and UVB) sunscreens is only one
element of safer sun practices. It is
also important to take the following
sun-safety measures:
SUN SAFE TIPS:
Wear Protective Clothing
A long sleeved shirt, pants, a wide-
brimmed har and sunglasses should
be worn where possible
Seek Shade
Remember that the sun's rays are
strongest between 10am and 4pm.
Learn the UV Index and be aware
of the strength of the sun's rays.
Avoid Tanning Beds
UV light from the sun and tanning beds
may cause skin cancer and wrinkling
Get Vitamin D Safely
Add vitamin supplements to a healthy
dient in consultation with your physician.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17452-370-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d697-8e05-e053-dbdaa90a074a | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17452-370-01 | MDSolarSciences SPF40 No Touch Body | 110 mL in 1 BOTTLE, SPRAY | SPRAY | 110 | 5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 5 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 5 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 5 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 5 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 5 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 5 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 5 | |
| Butyloctyl salicylate | INACTIVE INGREDIENT | 2EH13UN8D3 | 5 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 5 | |
| Diisopropyl Adipate | INACTIVE INGREDIENT | P7E6YFV72X | 5 | |
| POLYESTER-8 (1400 MW, CYANODIPHENYLPROPENOYL CAPPED) | INACTIVE INGREDIENT | T9296U138P | 5 | |
| Tetrahexyldecyl Ascorbate | INACTIVE INGREDIENT | 9LBV3F07AZ | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17452-370 | 17452-370-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Avobenzone | G63QQF2NOX | ACTIB |
| Octisalate | 4X49Y0596W | ACTIB |
| Octocrylene | 5A68WGF6WM | ACTIB |
| Alcohol | 3K9958V90M | IACT |
| Butyloctyl salicylate | 2EH13UN8D3 | IACT |
| POLYESTER-8 (1400 MW, CYANODIPHENYLPROPENOYL CAPPED) | T9296U138P | IACT |
| Diisopropyl Adipate | P7E6YFV72X | IACT |
| Tetrahexyldecyl Ascorbate | 9LBV3F07AZ | IACT |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | GEL / TOPICAL | 150 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | CREAM / TOPICAL | 170 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | SOLUTION / TOPICAL | 815 mg | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | LOTION / TOPICAL | 250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 26e47ef7-264d-4664-b54c-d67483b0a0e4 | 65c65fe9-0ffe-4bd3-acac-3c256d40d6af | 2010-10-15 | Warnings | 26e47ef7-264d-4664-b54c-d67483b0a0e4 65c65fe9-0ffe-4bd3-acac-3c256d40d6af |
Adverse event summaries are temporarily unavailable. Other product information remains available.